중환자실(ICU) 인공호흡기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the intensive care unit ventilators market size is expected to increase from USD 2.9 billion in 2025 to USD 3.10 billion in 2026 and reach USD 4.43 billion by 2031, growing at a CAGR of 6.99% over 2026-2031.

This report is Segmented by Mobility Type (Stationary, Portable), Product Type (High-End, Mid-End, Low-End), Mode (Volume-Controlled and More), Patient Age Group (Adult, Pediatric, Neonatal), Interface (Invasive, Non-Invasive), End-User (Hospitals and More), Technology (Mechanical, and More), and Geography (North America, Europe, and More). Market Forecasts are Provided in Terms of Value (USD).

Global Intensive Care Unit (ICU) Ventilators Market Trends and Insights

Surging Incidence of Acute Respiratory Distress Syndrome

ARDS remains a core demand driver for the ICU ventilators market. U.S. incidence stands at 64 per 100,000 population, and the condition accounts for 10%-15% of global ICU admissions. Mortality of 30%-50% keeps clinical focus on precision-titrated ventilation that limits lung injury. Seasonal wildfire smoke in North America and persistent air-quality challenges in South Asia elevate ARDS case peaks. As OECD populations age, hospitals front-load replacement cycles even while pandemic stockpiles depreciate. Together, these patterns sustain baseline procurement beyond crisis surges.

Government-Funded ICU Capacity Expansion in LMICs

Low- and middle-income countries allocate multiyear budgets to critical-care infrastructure. India's Ayushman Bharat program sets aside INR 64,180 crore for 2025-2026, with 12% geared to ventilators in district hospitals. Subsidies under the Production-Linked Incentive scheme reimburse up to 5% of incremental sales, shortening lead times for domestically assembled units. Mid-end mechanical ventilators priced under USD 25,000 meet technical requirements while aligning with fiscal constraints, expanding the ICU ventilators market in price-sensitive regions.

Supply-Chain Fragility for Critical Ventilator Components

Semiconductor and turbine shortages extend device lead times to 16-22 weeks. FDA guidance on supply resilience flags turbines and pressure transducers as high-risk parts. Precision-machined titanium housings rely on a limited vendor base in Germany and Japan, constraining portable production. Backlogs hamper timely fulfillment and limit revenue capture in the ICU ventilators market.

Other drivers and restraints analyzed in the detailed report include:

1. Integration of Turbine-Based Portable Ventilators
2. Rapid Installation of AI-Driven Closed-Loop Ventilation
3. Stringent Regulatory Re-Certification for Software-Driven Units

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Portable ventilators are forecast to grow at 7.50% CAGR through 2031, a rate that surpasses the 6.99% average for the ICU ventilators market. Demand arises from emergency services, military units, and home-care transitions that value battery autonomy and turbine blowers. Portable models bypass the hospital pipeline oxygen, enabling a broader geographic reach. Stationary systems, which captured 58.4% share in 2025, remain essential for high-acuity ICUs with integrated monitoring networks, yet overcapacity in developed markets lengthens their replacement intervals to nine years. The FDA guidance that clarifies battery testing streamlined approvals by three months, accelerating portable launches and supporting their climb within the ICU ventilators market.

Stationary units still dominate in tertiary hospitals that embed ventilators into networked alarm systems and centralized gas supplies. Maintenance contracts now emphasize remote diagnostics and software upgrades, helping vendors preserve margin despite slower unit turnover. As sustainability targets tighten, even large fixed platforms must meet lower wattage thresholds, nudging manufacturers to retrofit turbines and optimize airflow paths. These upgrades keep the stationary base relevant while portable expansion unlocks new revenue streams, balancing the mobility landscape of the ICU ventilators market.

Mid-end ventilators are projected to advance at a 7.35% CAGR, buoyed by emerging-market tenders that demand sophisticated modes at mid-tier prices. Manufacturers now embed airway pressure release ventilation and neurally adjusted ventilatory assist into sub-USD 20,000 units, narrowing functional gaps with high-end systems. High-end platforms held 52.1% share of the ICU ventilators market size in 2025, sustained by quaternary hospitals that require seamless EHR integration and advanced monitoring. Yet price premiums soften as mid-end units deliver comparable clinical outcomes.

Low-end devices maintain footholds in rural clinics and disaster stockpiles, but their limited feature sets and inability to meet new ISO alarm standards restrict volume-competitive focus, therefore, swings to mid-range models. Companies leverage AI-driven weaning algorithms to add value while holding costs, expanding mid-end traction in public procurement, and reshaping product mix across the ICU ventilators market.

Advanced and combined ventilation modes are expanding at 7.42% CAGR through 2031, outpacing high-frequency ventilation's 48.6% market share in 2025, as neonatal intensive care units adopt synchronized intermittent mandatory ventilation and volume-guarantee algorithms that minimize barotrauma in preterm infants. High-frequency ventilation remains the workhorse for severe ARDS and neonatal respiratory distress syndrome, delivering 300 to 900 breaths per minute to maintain alveolar recruitment while limiting peak airway pressures. Volume-controlled and pressure-controlled modes serve the bulk of adult ICU cases, offering clinician familiarity and regulatory approval across all geographies. Manufacturers are responding with hybrid platforms. Dragerwerk's Babylog VN800 offers high-frequency, volume-controlled, and neurally adjusted modes in a single device that reduce capital expenditure for hospitals managing diverse patient populations.

Geography Analysis

North America held 37.2% share in 2025, yet future growth is moderated by stockpile-driven overcapacity that delays fleet refresh. The region leads in AI-enabled closed-loop adoption and turbine portable penetration. Canada pilots carbon dashboards that score device emissions, tying procurement to net-zero milestones. Vendors increasingly package analytics subscriptions with hardware to unlock service revenue in the ICU ventilators market.

Asia-Pacific is the fastest-growing region at 7.23% CAGR through 2031. China issues accelerated clearances for domestic suppliers such as Mindray and Comen, while India's production incentives strive for USD 1.5 billion medical-device output by 2028.ASEAN harmonization trims regulatory timelines by six months. Japan's aging population, with 27% over 65 years in 2025, sustains ICU admissions for pneumonia and COPD. These dynamics enlarge the regional share of the ICU ventilators market.

Europe faces Medical Device Regulation recertification expenses averaging EUR 500,000 per line. High compliance cost favors incumbents but slows new product rollouts. Italy and Spain pilot leasing models that shift ventilator costs from capital to operating budgets, easing fiscal pressure on hospitals while maintaining flow in the ICU ventilators market.

1. Air Liquide
2. Allied Healthcare Products
3. Bunnell Inc.
4. Demcon
5. Dragerwerk
6. Fisher & Paykel Healthcare
7. GE Healthcare
8. Getinge
9. Hamilton Medical
10. ICU Medical
11. Koninklijke Philips
12. Medtronic
13. Mindray Medical International Inc.
14. Nihon Kohden
15. Resmed
16. Schiller
17. Shenzhen Comen Medical Instruments
18. Zoll Medical Corporation (Vyaire Medical Inc.)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Surging Incidence of Acute Respiratory Distress Syndrome (ARDS)
  • 4.2.2 Government-Funded ICU Capacity Expansion in LMICs
  • 4.2.3 Integration of Turbine-Based Portable Ventilators
  • 4.2.4 Rapid Installation of AI-Driven Closed-Loop Ventilation
  • 4.2.5 Rising Adoption of Non-Invasive Ventilation in General Wards
  • 4.2.6 Hospital Sustainability Mandates for Energy-Efficient Fleets
• 4.3 Market Restraints
  • 4.3.1 Supply-Chain Fragility for Critical Ventilator Components
  • 4.3.2 Stringent Regulatory Re-Certification for Software-Driven Units
  • 4.3.3 Persistent Post-Pandemic ICU Overcapacity in Developed Markets
  • 4.3.4 Uptake of High-Flow Nasal Cannula Curbing Ventilator Demand
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porters Five Forces Analysis
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Mobility Type
  • 5.1.1 Stationary Ventilators
  • 5.1.2 Portable Ventilators
• 5.2 By Product Type
  • 5.2.1 High-End ICU Ventilators
  • 5.2.2 Mid-End ICU Ventilators
  • 5.2.3 Low-End ICU Ventilators
• 5.3 By Mode
  • 5.3.1 Volume-Controlled Ventilation
  • 5.3.2 Pressure-Controlled Ventilation
  • 5.3.3 High-Frequency Ventilation
  • 5.3.4 Others (Combined / Advanced Modes, Synchronized Intermittent Mandatory Ventilation)
• 5.4 By Patient Age Group
  • 5.4.1 Adult
  • 5.4.2 Pediatric
  • 5.4.3 Neonatal
• 5.5 By Interface
  • 5.5.1 Invasive Ventilation
  • 5.5.2 Non-Invasive Ventilation
• 5.6 By End-user
  • 5.6.1 Hospitals
  • 5.6.2 Ambulatory Surgical Centers
  • 5.6.3 Specialty Clinics
  • 5.6.4 Others (Combined / Advanced Modes, Synchronized Intermittent Mandatory Ventilation)
• 5.7 By Technology (Value)
  • 5.7.1 Mechanical Ventilators
  • 5.7.2 Pnematic Ventilators
  • 5.7.3 Others (Combined / Advanced Modes, Synchronized Intermittent Mandatory Ventilation)
• 5.8 By Geography
  • 5.8.1 North America
    • 5.8.1.1 United States
    • 5.8.1.2 Canada
    • 5.8.1.3 Mexico
  • 5.8.2 Europe
    • 5.8.2.1 Germany
    • 5.8.2.2 United Kingdom
    • 5.8.2.3 France
    • 5.8.2.4 Italy
    • 5.8.2.5 Spain
    • 5.8.2.6 Rest of Europe
  • 5.8.3 Asia-Pacific
    • 5.8.3.1 China
    • 5.8.3.2 India
    • 5.8.3.3 Japan
    • 5.8.3.4 South Korea
    • 5.8.3.5 Australia
    • 5.8.3.6 Rest of Asia-Pacific
  • 5.8.4 Middle East and Africa
    • 5.8.4.1 GCC
    • 5.8.4.2 South Africa
    • 5.8.4.3 Rest of Middle East and Africa
  • 5.8.5 South America
    • 5.8.5.1 Brazil
    • 5.8.5.2 Argentina
    • 5.8.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Air Liquide Medical Systems
  • 6.3.2 Allied Healthcare Products Inc.
  • 6.3.3 Bunnell Inc.
  • 6.3.4 Demcon
  • 6.3.5 Dragerwerk AG & Co. KGaA
  • 6.3.6 Fisher & Paykel Healthcare Limited
  • 6.3.7 GE Healthcare
  • 6.3.8 Getinge AB
  • 6.3.9 Hamilton Medical
  • 6.3.10 ICU Medical Inc. (Smiths Medical)
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Medtronic plc
  • 6.3.13 Mindray Medical International Inc.
  • 6.3.14 Nihon Kohden Corporation
  • 6.3.15 ResMed
  • 6.3.16 Schiller AG
  • 6.3.17 Shenzhen Comen Medical Instruments
  • 6.3.18 Zoll Medical Corporation (Vyaire Medical Inc.)

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment